7th Edition of Cardiology World Conference
October 08-10, 2026 | Virtual Event
Metabolic and Systemic Heart Diseases
The relationship between metabolic disorders and heart disease is well-established, with conditions like insulin resistance, metabolic syndrome, and obesity playing major roles in the development of cardiovascular diseases. These systemic heart diseases often complicate the management of heart conditions, requiring tailored treatment strategies that address both the metabolic and cardiac aspects. Interventions such as weight management, glucose control, and the use of medications that target metabolic pathways can help reduce the burden of these diseases on the heart. With early detection and proper management, it is possible to prevent the progression of metabolic and systemic heart diseases, ultimately improving patient outcomes and reducing the risk of severe cardiovascular events.
Yochai Birnbaum
Baylor College of Medicine, United States
Uwe Peter Tigor
Auxilius Pharma, United States, United States
Federico Benetti
Benetti Foundation, Argentina
Sergey Suchkov
Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Syed Raza
Awali Hospital, Bahrain
Sekib Sokolovic
ASA Hospital Sarajevo, Bosnia and Herzegowina
Thomas J Webster
Brown University, United StatesSubmit your abstract Today
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States